Albany Molecular Research (AMRI), a global contract research and manufacturing organisation, has appointed Michael Nolan as vice president, chief financial officer (CFO) and treasurer, succeeding Mark Frost.
Nolan was most recently vice president, finance, financial planning and analysis at the Delaware North Companies. From 2009 through early 2012, he was vice president, finance, analytical instruments group at Thermo Fisher Scientific, where he was responsible for the global financial operations of a portfolio with revenue of US$3bn operating across three divisions with 15 business units, 41 plant sites and 9,700 employees.
Prior to Thermo Fisher Scientific, Nolan held positions of increasing responsibility at ALCAN, which was later acquired by Rio Tinto. While at Rio Tinto, he was accountable for leading the integration of 13 global ALCAN and Rio Tinto functions, including legal, company secretarial, business development and all finance functions including both the corporate and business teams.
Nolan began his career in 1989 at EI du Pont de Nemours and received his MBA from The University of Windsor and a BA in Economics from The University of Western Ontario.
On the second day of this year's AFP conference Trump's potential tax reform, using synthetic debt and the expected benefits of SWIFT GPI were all hotly discussed topics.
Today CGI and GTNews have announced the launch of the fifth annual Transaction Banking survey report, which offers which offers critical insight into the corporate-to-bank relationship.
On-Demand Treasury Management Solutions continue to gain increased adoption in the US and EMEA regions.
Treasurers are being expected to do more work with fewer resources than ever before, so it is little wonder that the automation of day-to-day operations was highly discussed on the second day of EuroFinance, the annual treasury event held in Barcelona this week.